Rangroo Thrane V, Thrane AS, Chang J, Alleluia V, Nagelhus EA, Nedergaard M (2012) Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy
Retatrutide * Triple agonist: GLP-1 + GIP + Glucagon * Pushing biology harder * ~2528% weight loss in trials * Once weekly injection This is efficacy chasing bariatric territory Orforglipron * Oral, non-peptide GLP-1 * No injection, no cold chain drama * Strong A1C + weight data vs oral sema This is scalability at massive level In one line: Retatrutide stretches the ceiling
At THE RE/ CLINIC in Sandy, UT, we often assist patients seeking advanced therapies like peptides and stem cell treatments to support tissue repair and recovery
While they may help support healthy aging when taken consistently over time, we still recommend prioritizing healthy habits, like a well-rounded diet and regular exercise plan